[1] Niesporek S, Denkert C, Weichert W, et al.  Expression of lysophosphatidic acid acyltransferase beta(LPAAT-beta)in ovarian carcinoma: correlation with tumour grading and prognosis[J]. Br J Cancer, 2005, 92(9): 1729-1736.   doi: 10.1038/sj.bjc.6602528
[2] Jonkers J, Moolenaar WH.  Mammary tumorigenesis through LPA receptor signaling[J]. Cancer Cell, 2009, 15(6): 457-459.   doi: 10.1016/j.ccr.2009.05.003
[3] Yu S, Murph MM, Lu Y, et al.  Lysophosphatidic acid receptorsdetermine tumorigenicity and aggressiveness of ovarian cancer cells[J]. J Natl Cancer Inst, 2008, 100(22): 1630-1642.   doi: 10.1093/jnci/djn378
[4] Ren J, Xiao YJ, Singh LS, et al.  Lysophosphatitic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhsion, migration, and invasion of ovarian cancer cells[J]. Cancer Res, 2006, 66(6): 3006-3014.   doi: 10.1158/0008-5472.CAN-05-1292
[5] Shida D, Kitayama J, Yamaguchi H, et al.  Lysophosphatidic acid transactivates both c-Met and epidermal growth factor receptor, and induces cyclooxygenase-2 expression in human colon cancer LoVo cells[J]. World J Gastroenterol, 2005, 11(36): 5638-5643.   doi: 10.3748/wjg.v11.i36.5638
[6] 徐文生, 黄艳丽, 蒙玉刚, 等.  卵巢恶性上皮性肿瘤血浆溶血磷脂酸与CA125诊断价值的对比观察[J]. 中华肿瘤防治杂志, 2008, 15(11): 840-842.   doi: 10.3969/j.issn.1673-5269.2008.11.012
[7] Sutphen R, Xu Y, Wilbanks GD, et al.  Lysophospholipids are potential biomarkers of ovarion cancer[J]. Cancer Epidemiol Biomarkers Prev, 2004, 13(7): 1185-1191.
[8] 肖焕擎, 杨洁, 孙政, 等.  溶血磷脂酸在胃恶性上皮性肿瘤患者中表达及意义[J]. 临床和实验医学杂志, 2008, 7(1): 75-76.   doi: 10.3969/j.issn.1671-4695.2008.01.048